AAA

ARCOMA AB

No trades
See on Supercharts
Market capitalization
‪154.27 M‬SEK
‪2.56 M‬SEK
‪163.02 M‬SEK
Beta (1Y)
0.55

About ARCOMA AB

CEO
Leire Mattias
Website
Headquarters
Växjö
Employees (FY)
32
Founded
1990
ISIN
SE0006219176
FIGI
BBG007J28RX5
Arcoma AB engages in the provision of digital radiographic systems for use in hospitals, clinics, imaging centers, and private practices of all sizes. The firm develops and manufactures x-ray equipment for the healthcare industry. Its products include fixed, tethered, and wireless flat panel detectors, as well as positioning devices, stands, tables, generators, and software. The company was founded by Per Hermansson in 1990 and is headquartered in Vaxjo, Sweden.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ARCOMA is 11.70 SEK — it has decreased by 1.27% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange ARCOMA AB stocks are traded under the ticker ARCOMA.
ARCOMA stock is 1.28% volatile and has beta coefficient of 0.55. Check out the list of the most volatile stocks — is ARCOMA AB there?
Yes, you can track ARCOMA AB financials in yearly and quarterly reports right on TradingView.
ARCOMA stock has risen by 0.86% compared to the previous week, the month change is a 5.65% fall, over the last year ARCOMA AB has showed a 30.73% increase.
ARCOMA net income for the last quarter is ‪2.52 M‬ SEK, while the quarter before that showed ‪1.98 M‬ SEK of net income which accounts for 27.30% change. Track more ARCOMA AB financial stats to get the full picture.
Today ARCOMA AB has the market capitalization of ‪156.25 M‬, it has increased by 1.69% over the last week.
No, ARCOMA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ARCOMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ARCOMA AB stock right from TradingView charts — choose your broker and connect to your account.
ARCOMA reached its all-time high on Jan 7, 2021 with the price of 26.30 SEK, and its all-time low was 3.55 SEK and was reached on Jan 26, 2017.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 32.00 employees. See our rating of the largest employees — is ARCOMA AB on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ARCOMA AB technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ARCOMA AB stock shows the buy signal. See more of ARCOMA AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ARCOMA AB EBITDA is ‪14.31 M‬ SEK, and current EBITDA margin is 5.61%. See more stats in ARCOMA AB financial statements.